Nov 15, 2020
Scientists develop next-generation immunotherapy now entering early phase clinical trials
Posted by Jeff Myers in category: biotech/medical
Cancer Research UK scientists have invented a new experimental drug that aims to harness the full power of the body’s own immune system, launching a two-pronged response against cancer, according to a study published in Nature Cancer today.
In the study, partly funded by Cancer Research UK, the new immunotherapy drug, which targets suppressive ‘regulatory’ immune cells inside a tumor, significantly improved long-term survival in animal models even when used without other drugs.